Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last 1,144 INR
Change Today +32.70 / 2.94%
Volume 496.6K
STR On Other Exchanges
Natl India
As of 7:06 AM 07/1/15 All times are local (Market data is delayed by at least 15 minutes).

strides arcolab ltd (STR) Snapshot

Previous Close
Day High
Day Low
52 Week High
05/29/15 - 1,275
52 Week Low
07/10/14 - 529.63
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for STRIDES ARCOLAB LTD (STR)

Related News

No related news articles were found.

strides arcolab ltd (STR) Related Businessweek News

View More BusinessWeek News

strides arcolab ltd (STR) Details

Strides Arcolab Limited, a pharmaceutical company, develops, manufactures, and sells pharmaceutical products in India and internationally. The company develops generic pharmaceutical product portfolio in therapeutic segments, such as immune-suppressants, anti-virals, antibiotics, complex vitamins, and anti-lipidemics; and offers general tablets, hard and soft gelatin capsules, sachets, potent drugs, liquid filled hard gel capsules, creams, ointments, and liquids and syrups. In addition, it provides branded generic products; supplies drugs in the anti-retroviral and anti-malaria segments; and is engaged in bio generics business, as well as offers and oncology, nephrology, critical care products. The company was formerly known as Strides Pharmaceuticals Private Limited and changed its name to Strides Arcolab Limited in 1996. Strides Arcolab Limited was founded in 1990 and is headquartered in Bengaluru, India.

2,700 Employees
Last Reported Date: 05/18/13
Founded in 1990

strides arcolab ltd (STR) Top Compensated Officers

Founder, Executive Vice Chairman, Managing Di...
Total Annual Compensation: 53.9M
Compensation as of Fiscal Year 2014.

strides arcolab ltd (STR) Key Developments

Strides Arcolab Ltd. Presents at India Corporate Day - Hong Kong 2015, Jun-17-2015

Strides Arcolab Ltd. Presents at India Corporate Day - Hong Kong 2015, Jun-17-2015 . Venue: Macquarie Hong Kong Office, Hong Kong.

Strides Arcolab Ltd. Presents at India Corporate Day 2015, Jun-15-2015

Strides Arcolab Ltd. Presents at India Corporate Day 2015, Jun-15-2015 . Venue: The Fullerton Hotel, Singapore.

Strides Does Not Plan Acquisitions In India

Strides Arcolab Ltd. (BSE:532531) says international business is offering better value accretion than India and that’s the reason Strides does not intend to make major capital investments in India and is also not keen on acquisitions in the domestic market.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
STR:IN 1,143.55 INR +32.70

STR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
AstraZeneca PLC 4,115 GBp +95.50
Endo International PLC $80.66 USD +1.00
Johnson & Johnson $98.43 USD +0.97
Merck & Co Inc $57.69 USD +0.76
Pfizer Inc $33.81 USD +0.275
View Industry Companies

Industry Analysis


Industry Average

Valuation STR Industry Range
Price/Earnings 100.0x
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow 6.3x
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact STRIDES ARCOLAB LTD, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at